Validation of the Finnegan Neonatal Abstinence Syndrome Tool -short form

Advances in Neonatal Care

Volumn 13, Issue 6, 2013, Pages 430-437

  Maguire, Denise ^a   Cline, Genieveve J ^b   Parnell, Lisa ^c   Tai, Chun Yi ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b JOHNS HOPKINS ALL CHILDREN S HOSPITAL   (United States)

^c Western Baptist Hospital   (United States)

Author keywords

Abstinence syndrome; Assessment; Finnegan; Neonate; Symptoms

Indexed keywords

NARCOTIC ANALGESIC AGENT;

ARTICLE; EQUIPMENT; FACTORIAL ANALYSIS; FEMALE; HUMAN; MALE; NEWBORN; NURSING; PREMATURITY; PRINCIPAL COMPONENT ANALYSIS; PSYCHOMETRY; QUESTIONNAIRE; VALIDATION STUDY; WITHDRAWAL SYNDROME;

ANALGESICS, OPIOID; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; NEONATAL ABSTINENCE SYNDROME; PRINCIPAL COMPONENT ANALYSIS; PSYCHOMETRICS; QUESTIONNAIRES;

EID: 84892586068     PISSN: 15360903     EISSN: 15360911     Source Type: Journal    
DOI: 10.1097/ANC.0000000000000033     Document Type: Article

References (23)

1. Abrahams R, Chase C, Desmoulin J, et al. The opioid dependent mother and newborn: an update. The 6th Annual Ivey Symposium. J Popul Ther Clin Pharmacol. 2012;19(1):e73-e77.
2. Maguire D, Webb M, Passmore D, Cline G. NICU nurses' lived experience: caring for infants with neonatal abstinence syndrome. Adv Neonatal Care. 2012;12(5):281-285.
3. Murphy-Oikonen J, Brownlee K, Montelpare W, Gerlach K. The experiences of NICU nurses in caring for infants with neonatal abstinence syndrome. Neonatal Netw. 2010;29(5):307-313.
4. French ED, Pituch M, Brandt J, Pohorecki S. Improving interactions between substance abusing mothers and their substance-exposed newborns. J Obstet Gynecol Neonatal Nurs. 1998;27(3):262-269.
5. Osborn DA, Jeffery HE, Cole MJ. Opiate treatment for opiate withdrawal in newborn infants. Cochrane Database Syst Rev. 2010;10:CD002059.
6. Osborn DA, Jeffery HE, Cole MJ. Sedatives for opiate withdrawal in newborn infants. Cochrane Database Syst Rev. 2010;10:CD002053.
7. SAMSHA. Results from the 2011 National Survey on Drug Use and Health: summary of national findings. Rockville, MD: HHS; 2012.
8. Greenfield SF, Back SE, Lawson K, Brady KT. Substance abuse in women. Psychiatr Clin North Am. 2010;33(2):339-355.
9. Finnegan LP, MacNew BA. Care of the addicted infant. Am J Nurs. 1974;74(4):685-693.
10. Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA. 2012;307(18):1934-1940.
11. Finnegan LP, Connaughton JF Jr, Kron RE, Emich JP. Neonatal abstinence syndrome: assessment and management. Addict Dis. 1975;2(1/2):141-158.
12. Zahorodny W, Rom C, Whitney W, et al. The Neonatal Withdrawal Inventory: a simplified score of newborn withdrawal. J Dev Behav Pediatr. 1998;19(2):89-93.
13. Finnegan L, Kaltenbach K. Neonatal abstinence syndrome. In: Hoekelman R, Friedman S, Nelson N, Seidel H, eds. Pediatric Primary Care. 2nd ed. St Louis, MO: Mosby; 1992.
14. Zimmermann-Baer U, Notzli U, Rentsch K, Bucher HU. Finnegan neonatal abstinence scoring system: normal values for first 3 days and weeks 5-6 in non-addicted infants. Addiction. 2010;105(3): 524-528.
15. American Academy of Pediatrics, Task Force on Sudden Infant Death Syndrome. The changing concept of sudden infant death syndrome: diagnostic coding shifts, controversies regarding the sleeping environment, and new variables to consider in reducing risk. Pediatrics. 2005;116(5):1245-1255.
16. Tabachnick B, Fiedell L. Using Multivariate Statistics. 4th ed. Boston, MA: Allyn & Bacon; 2001.
17. D'Apolito K. Comparison of a rocking bed and standard bed for decreasing withdrawal symptoms in drug-exposed infants. MCN Am J Matern Child Nurs. 1999;24(3):138-144.
18. D'Apolito K. Neo advances: enhancing the care of drug-exposed infants. http://www.neoadvances.com/index.html. Accessed June 27, 2013.
19. Cattell RB. The scree test for the number of factors. Multivariate Behav Res. 1966;1(2):245-276.
20. Bartlett MS. Tests of significant in factor analysis. Br J Stat Psychol. 1950;3(2):77-85.
21. Bartlett MS. A further note on tests of significance in factor analysis. Br J Stat Psychol. 1951;49(1):1-2.
22. Kaiser HF. A second-generation little jiffy. Psychometrika. 1970;35(4):401-415.
23. D'Apolito K, Hepworth JT. Prominence of withdrawal symptoms in polydrug-exposed infants. J Perinat Neonatal Nurs. 2001;14(4): 46-60.